全球新药研发机制分布概览

Global new drug development is distributed across different 'mechanisms'. This means that new drugs are being developed using a variety of approaches, each with its own set of advantages and disadvantages. Some of the most common 'mechanisms' used in new drug development include:

• Small molecule drug discovery: This is the traditional approach to new drug development, and it involves identifying and developing small molecules that can interact with specific targets in the body.
• Biologics: Biologics are large, complex molecules that are derived from living organisms. They are often used to treat diseases that cannot be effectively treated with small molecule drugs.
• Gene therapy: Gene therapy involves modifying the genetic makeup of cells to treat diseases. This approach is still in its early stages of development, but it has the potential to revolutionize the treatment of many diseases.
• Cell therapy: Cell therapy involves using cells to treat diseases. This approach is also in its early stages of development, but it has the potential to treat a wide range of diseases, including cancer, autoimmune diseases, and genetic disorders.

The distribution of new drug development across different 'mechanisms' is constantly evolving. As new technologies and approaches are developed, the landscape of new drug development is likely to change significantly in the years to come.